Long-term consequences of polycystic ovary syndrome


Cite item

Full Text

Abstract

Polycystic ovary syndrome (PCOS) is the most common chronic endocrine disease in women. The prevailing complaints at a young age are menstrual irregularities, infertility, and hyperandrogenism-related problems. However, metabolic disorder-induced complications have been in the foreground over years. The review gives the current ideas on a change of clinical manifestations in the natural course of PCOS, as well as the pathogenetically grounded prevention of complications in patients.

About the authors

O R Grigoryan

ФГБУ «Эндокринологический научный центр» Минздрава России; ФГБОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

N S Zhemaite

ФГБУ «Эндокринологический научный центр» Минздрава России

Москва, Россия

N N Volevodz

ФГБУ «Эндокринологический научный центр» Минздрава России; ФГБОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

E N Andreeva

ФГБУ «Эндокринологический научный центр» Минздрава России; ФГБОУ ВО «МГМСУ им. А.И. Евдокимова» Минздрава России

Москва, Россия

G A Melnichenko

ФГБУ «Эндокринологический научный центр» Минздрава России; ФГБОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

I I Dedov

ФГБУ «Эндокринологический научный центр» Минздрава России; ФГБОУ ВО «Первый МГМУ им. И.М. Сеченова» Минздрава России

Москва, Россия

References

  1. Boomsma C, Eijkemans M, Hughes E, Visser G, Fauser B, Macklon N. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Human Reproduction Update. 2006;12(6):673-683. https://doi.org/10.1093/humupd/dml036
  2. Veltman-Verhulst S, van Haeften T, Eijkemans M, de Valk H, Fauser B, Goverde A. Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome. Human Reproduction. 2010;25(12):3123-3128. https://doi.org/10.1093/humrep/deq272
  3. Fauser B, Tarlatzis B, Rebar R et al. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility. 2012;97(1):28-38.e25. https://doi.org/10.1016/j.fertnstert.2011.09.024
  4. Legro R. Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women. Journal of Clinical Endocrinology & Metabolism. 1999;84(1):165-169. https://doi.org/10.1210/jc.84.1.165
  5. Moran L, Misso M, Wild R, Norman R. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update. 2010;16(4):347-363. https://doi.org/10.1093/humupd/dmq001
  6. Rizzo M, Berneis K, Spinas G, Rini G, Carmina E. Long-term consequences of polycystic ovary syndrome on cardiovascular risk. Fertility and Sterility. 2009;91(4):1563-1567. https://doi.org/10.1016/j.fertnstert.2008.09.070
  7. de Groot P, Dekkers O, Romijn J, Dieben S, Helmerhorst F. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Human Reproduction Update. 2011;17(4):495-500. https://doi.org/10.1093/humupd/dmr001
  8. Mani H, Levy M, Davies M, Morris D, Gray L, Bankart J, Blackledge H, Khunti K, Howlett T. Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study. Clin Endocrinol (Oxf) 2013; 78(6): 926-34. https://doi.org/10.1111/cen.12068
  9. Morgan C, Jenkins-Jones S, Currie C, Rees D. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. J Clin Endocrinol Metab. 2012;97(9):3251-3260. https://doi.org/10.1210/jc.2012-1690
  10. Wild S, Pierpoint T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb). 2000;3(2):101-105. https://doi.org/10.1080/1464727002000198781
  11. Shaw L, Bairey Merz C, Azziz R et al. Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation. The Journal of Clinical Endocrinology & Metabolism. 2008;93(4):1276-1284. https://doi.org/10.1210/jc.2007-0425
  12. Krentz A, von Mühlen D, Barrett-Connor E. Searching for polycystic ovary syndrome in postmenopausal women. Menopause. 2007;14(2):284-292. https://doi.org/10.1097/gme.0b013e31802cc7ab
  13. Talbott E, Guzick D, Sutton-Tyrrell K et al. Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20(11):2414-2421. https://doi.org/10.1161/01.atv.20.11.2414
  14. Talbott E, Zborowski J, Rager J, Boudreaux M, Edmundowicz D, Guzick D. Evidence for an Association between Metabolic Cardiovascular Syndrome and Coronary and Aortic Calcification among Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2004;89(11):5454-5461. https://doi.org/10.1210/jc.2003-032237
  15. Soares G, Vieira C, Martins W et al. Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome? Clinical Endocrinology. 2009;71(3):406-411. https://doi.org/10.1111/j.1365-2265.2008.03506.x
  16. Luque-Ramirez M, Mendieta-Azcona C, Alvarez-Blasco F, Escobar-Morreale H. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome. Human Reproduction. 2007;22(12):3197-3203. https://doi.org/10.1093/humrep/dem324
  17. Christian R, Dumesic D, Behrenbeck T, Oberg A, Sheedy P, Fitzpatrick L. Prevalence and Predictors of Coronary Artery Calcification in Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 2003;88(6):2562-2568. https://doi.org/10.1210/jc.2003-030334
  18. Nitsche K, Ehrmann D. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome. Best Practice & Research Clinical Endocrinology & Metabolism. 2010;24(5):717-730. https://doi.org/10.1016/j.beem.2010.08.001
  19. Reaven G. The Metabolic Syndrome: Requiescat in Pace. Clinical Chemistry. 2005;51(6):931-938. https://doi.org/10.1373/clinchem.2005.048611
  20. Jovanovic V, Carmina E, Lobo R. Not all women diagnosed with PCOS share the same cardiovascular risk profiles. Fertility and Sterility. 2010;94(3):826-832. https://doi.org/10.1016/j.fertnstert.2009.04.021
  21. Chittenden B, Fullerton G, Maheshwari A, Bhattacharya S. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reproductive BioMedicine Online. 2009;19(3): 398-405. https://doi.org/10.1016/s1472-6483(10)60175-7
  22. Peigné M, Dewailly D. Long term health risks of PCOS. Gynecology Forum. 2013;18(4):28-32. https://doi.org/10.1016/j.ando.2014.07.111
  23. Schildkraut J, Schwingl P, Bastos E, Evanoff A, Hughes C. Epithelial Ovarian Cancer Risk Among Women With Polycystic Ovary Syndrome. Obstetrics & Gynecology. 1996;88(4):554-559. https://doi.org/10.1016/0029-7844(96)00226-8
  24. Pierpoint T, McKeigue P, Isaacs A, Wild S, Jacobs H. Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up. Journal of Clinical Epidemiology. 1998;51(7):581-586. https://doi.org/10.1016/s0895-4356(98)00035-3

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies